The General Pharmaceutical Council made the point bluntly in its April 2025 statement, warning that non-medicinal, unregulated, unlicensed products like Lemon Bottle have potentially caused serious harm and that pharmacies should not be supplying it as if it were a medicine
Long-term use, typically defined as over a year, may be associated with certain risks
Some clinical trials have been conducted on the repurposing of pioglitazone for PD treatment
The serendipitous discovery of exendin-4 led to the development of exenatide immediate-release (exenatide IR, Byetta), a synthetic version of exendin-4 with C-terminal amidation to enhance its stability [ Figure 2 , Table 1 ], which became the first FDA-approved GLP-1RA in 2005 for the treatment of T2DM in adults [ Table 2 ]
Peuke and Rennenberg 2005
If you have additional questions, Pierre Rojas, DO is here to answer your questions and get you started